Trandolapril
Product manufactured by Lupin Pharmaceuticals, Inc.
Indications and Purposes
| Indications And Usage Hypertension Trandolapril Tablets Are Indicated For The Treatment Of Hypertension. It May Be Used Alone Or In Combination With Other Antihypertensive Medication Such As Hydrochlorothiazide. Heart Failure Post Myocardial Infarction Or Left-Ventricular Dysfunction Post Myocardial Infarction Trandolapril Tablets Are Indicated In Stable Patients Who Have Evidence Of Left-Ventricular Systolic Dysfunction (Identified By Wall Motion Abnormalities) Or Who Are Symptomatic From Congestive Heart Failure Within The First Few Days After Sustaining Acute Myocardial Infarction. Administration Of Trandolapril To Caucasian Patients Has Been Shown To Decrease The Risk Of Death (Principally Cardiovascular Death) And To Decrease The Risk Of Heart Failure-Related Hospitalization (See Clinical Pharmacology -Heart Failure Or Left-Ventricular Dysfunction Post Myocardial Infarction For Details Of The Survival Trial ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Trandolapril |
|
ZINC1853205 |